Cardioprotective effect of sevoflurane in patients with coronary artery disease undergoing vascular surgery

Saudi Journal of Anaesthesia

Volumn 6, Issue 2, 2012, Pages 125-130

  Bassuoni, Ahmed S ^a   Amr, Yasser M ^a  

^a TANTA UNIVERSITY HOSPITAL   (Egypt)

Author keywords

cardioprotective; Coronary artery disease; sevoflurane; vascular surgery

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FENTANYL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; NITRIC ACID DERIVATIVE; PROPOFOL; ROCURONIUM; SEVOFLURANE; TROPONIN I;

ADULT; ANESTHESIA INDUCTION; ARTICLE; CARDIOVASCULAR RESPONSE; CLINICAL EVALUATION; CONTINUOUS INFUSION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; ELECTROCARDIOGRAM; FEMALE; HEART HEMODYNAMICS; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART VENTRICLE EXTRASYSTOLE; HUMAN; HYPERTENSION; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT DEPRESSION; TACHYCARDIA; VASCULAR SURGERY;

EID: 84862560153     PISSN: 1658354X     EISSN: 09753125     Source Type: Journal    
DOI: 10.4103/1658-354X.97024     Document Type: Article

References (20)

1. Landesberg G, Mosseri M, Zahger D, Wolf Y, Perouansky M, Anner H, et al. Myocardial infarction after vascular surgery: The role of prolonged, stress-induced, ST depression-type ischemia. J Am Coll Cardiol 2001:37;1839-45. (Pubitemid 32499968)
2. De Hert SG, ten Broecke PW, Mertens E, Van Sommeren EW, De Blier IG. Sevoflurane but not propofol preserves myocardial function in coronary surgery patients. Anesthesiology 2002:97;42-9. (Pubitemid 34733920)
3. Conzen PF, Fisher S, Detter C, Peter K. Sevoflurane provides greater protection on the myocardium than propofol in patients undergoing off-pump coronary artery bypass surgery. Anesthesiology 2003:99;826-33. (Pubitemid 37186071)
4. Husedžinović I, Barišin S, Bradić N, Milanović R. Early cardioprotective effect of sevoflurane on left ventricular performance during coronary artery bypass grafting on a beating heart: Randomized controlled study. Croat Med J 2007;48:333-40. (Pubitemid 47035683)
5. Landoni G, Biondi-Zoccai GG, Zangrillo A, Bignami E, D'Avolio S, Marchetti C, et al. Desflurane and sevoflurane in cardiac surgery: A meta-analysis of randomized clinical trials. J Cardiothorac Vasc Anesth 2007;21:502-11. (Pubitemid 47135634)
6. A CC/AHA 2007 Guidelines on Perioperative cardiovascular evaluation and care for non-cardiac surgery. A report of the American College of Cardiology/American Heart Association task force on practice guidelines. J Am Coll Cardiol 2007;50:159-42.
7. Lurati Buse GA, Seeberger MD, Schumann RM, Bürgler D, Schwab HS, Bolliger D, et al. Impact of the American College of Cardiology/American Heart Association guidelines for interpretability of continuous electrocardiography on the association of silent ischemia with troponin release after major noncardiac surgery. J Electrocardiol 2009;42:455-61.
8. Thygesen K, Alpert JS, White HD, Jaffe AS, Apple FS, Galvani M, et al. Universal definition of myocardial infarction. Circulation 2007;116:2634-53. (Pubitemid 350182388)
9. Flu WJ, Schouten O, van Kuijk JP, Poldermans D. Perioperative cardiac damage in vascular surgery patients. Eur J Vasc Endovasc Surg 2010;40:1-8.
10. De Hert SG. Cardioprotection by Volatile Anesthetics: What About Noncardiac Surgery? J Cardiothorac Vasc Anesth. 2011;25:899-901
11. Bursi F, Babuin L, Barbieri A, Politi L, Zennaro M, Grimaldi T, et al. Vascular surgery patients: Perioperative and long-term risk according to the ACC/AHA guidelines, the additive role of postoperative troponin elevation. Eur Heart J 2005;26:2448-56. (Pubitemid 41552975)
12. Leung JM, Voskanian A, Bellows WH, Pastor D. Automated electrocardiograph ST-segment trending monitors: Accuracy in detecting myocardial ischemia. Anesth Analg 1998; 87:4-10. (Pubitemid 28311601)
13. De Hert SG, Longrois D, Yang H, Fleisher LA. Does the use of a volatile anesthetic regimen attenuate the incidence of cardiac events after vascular surgery? Acta Anaesthesiol Belg 2008;59:19-25. (Pubitemid 351500616)
14. Landoni G, Fochi O, Bignami E, Calabrò MG, D'Arpa MC, Moizo E, et al.Cardiac protection by volatile anesthetics in non-cardiac surgery? A meta-analysis of randomized controlled studies on clinically relevant endpoints. HSR Proc Intensive Care Cardiovasc Anesth 2009;4:28-33.
15. Zangrillo A, Testa V, Aldrovandi V, Tuoro A, Casiraghi G, Cavenago F, et al. Volatile agents for cardiac protection in noncardiac surgery: A randomized controlled study. J Cardiothorac Vasc Anesth 2011; 25: 902-7.
16. De Hert SG, Van der Linden PJ, Cromheecke S, Meeus R, Nelis A, Van Reeth V, et al. Cardioprotective properties of sevoflurane in patients undergoing coronary surgery with cardiopulmonary bypass are related to the modalities of its administration. Anesthesiology 2004;101:299-310. (Pubitemid 38988484)
17. Kloner RA, Jennings RB. Consequences of brief ischemia: Stunning, preconditioning, and their clinical implications: part 2. Circulation 2001;104:3158-67. (Pubitemid 34014074)
18. Raby KE, Goldman L, Cook EF, Rumerman J, Barry J, Creager MA, et al. Long-term prognosis of myocardial ischemia detected by Holter monitoring in peripheral vascular disease. Am J Cardiol 1990;66:1309-13.
19. Landesberg G, Luria MH, Cotev S, Eidelman LA, Anner H, Mosseri M, et al. Importance of long-duration postoperative ST-segment depression in cardiac morbidity after vascular surgery. Lancet 1993;341:715-9. (Pubitemid 23085177)
20. Godet G, Dumerat M, Baillard C, Ben Ayed S, Bernard MA, Bertrand M, et al. Cardiac troponin I is reliable with immediate but not medium-term cardiac complications after abdominal aortic repair. Acta Anaesthesiol Scand 2000;44:592-7. (Pubitemid 30233026)